Molecule Structure

Scientific Name

Levodopa

Description of the Drug

Levodopa is a dopamine precursor used in the management of Parkinson’s disease, often in combination with carbidopa, as well as other conditions associated with parkinsonism.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01235

Brand Name(s)

Bendopa, Brocadopa, Dopar, Inbrija, Larodopa

Company Owner(s)

Organon Llc, Watson Laboratories Inc, Kv Pharmaceutical Co, Abbvie Inc, Shire Development Inc, Mylan Pharmaceuticals Inc, Scs Pharmaceuticals, Impax Laboratories Inc, Rising Pharma Holdings Inc, Avion Pharmaceuticals Llc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Dopamine D3 receptor SINGLE PROTEIN AGONIST CHEMBL234

Unichem Links

SureChEMBL SCHEMBL22655
PharmGKB PA450213
Human Metabolome Database HMDB0000181
DrugBank DB01235
PubChem: Thomson Pharma 15219946 15120911
PubChem 6047 6971033
Mcule MCULE-8112075430 MCULE-4743781842
NMRShiftDB 60021386
LINCS LSM-5481
Nikkaji J9.225H
PDBe DAH
BindingDB 60928
EPA CompTox Dashboard DTXSID9023209
DrugCentral 1567
Metabolights MTBLC15765 MTBLC57504
Brenda 175307 125744 2636 92715 2562 7593 195618 49535 15521 1782 20877 50079 120429 2961 112509 136312 84012 22129 20332 16206 320 15732
Rhea 57504
ChemicalBook CB2402938
Guide to Pharmacology 3639
rxnorm INBRIJA LEVODOPA
KEGG Ligand C00355
ChEBI 15765 57504
ZINC ZINC000000895199